Many patients suffer not only from respiratory symptoms due to their COVID-19 disease, but also from significantly reduced physical performance. A patent-protected tablet (CICR-NAM) developed at the ...
Charles M. Covit ’27, a Crimson Editorial editor, lives in Lowell House. “Hi Dad, I am speaking to you from Mefalsim,” the man says gleefully, referring to the Israeli Kibbutz by the Gaza border.